EBR:AGFB • BE0003755692
The current stock price of AGFB.BR is 0.4965 EUR. In the past month the price decreased by -0.7%. In the past year, price decreased by -45.97%.
ChartMill assigns a technical rating of 1 / 10 to AGFB.BR. When comparing the yearly performance of all stocks, AGFB.BR is a bad performer in the overall market: 94.68% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR. While AGFB.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months AGFB.BR reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS decreased by -111.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.65% | ||
| ROE | -25.44% | ||
| Debt/Equity | 0.57 |
11 analysts have analysed AGFB.BR and the average price target is 0.88 EUR. This implies a price increase of 78.05% is expected in the next year compared to the current price of 0.4965.
For the next year, analysts expect an EPS growth of 14.29% and a revenue growth -3.86% for AGFB.BR
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EQS | EQUASENS | 11.33 | 520.331M | ||
| GPI | GPI SPA | 16.94 | 485.11M | ||
| ALMDT | MEDIAN TECHNOLOGIES | N/A | 178.826M | ||
| ALCGM | CEGEDIM SA | 7.13 | 169.2M | ||
| AJ91 | DOCCHECK AG | N/A | 65.403M | ||
| M3V | MEVIS MEDICAL SOLUTIONS AG | N/A | 44.408M | ||
| ALINS | INTRASENSE SAS | N/A | 13.127M |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital systems for the printing industry, the healthcare sector, and specific industrial applications. The company is headquartered in Mortsel, Antwerpen and currently employs 4,741 full-time employees. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The firm is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.
AGFA-GEVAERT NV
Septestraat 27
Mortsel ANTWERPEN BE
Employees: 4765
Phone: 3234442111
Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital systems for the printing industry, the healthcare sector, and specific industrial applications. The company is headquartered in Mortsel, Antwerpen and currently employs 4,741 full-time employees. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The firm is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.
The current stock price of AGFB.BR is 0.4965 EUR. The price increased by 0.3% in the last trading session.
AGFB.BR does not pay a dividend.
AGFB.BR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The Revenue of AGFA-GEVAERT NV (AGFB.BR) is expected to decline by -3.86% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
You can find the ownership structure of AGFA-GEVAERT NV (AGFB.BR) on the Ownership tab.